ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
Novo Nordisk A/S B Shares ADRhedged
22.35
+0.0826
0.37%
盘后:
22.34
-0.0145
-0.06%
16:10 EDT
成交量:
3,176.00
成交额:
6.91万
市值:
424.74万
市盈率:
- -
高:
22.39
开:
20.04
低:
20.01
收:
22.27
52周最高:
43.73
52周最低:
19.00
股本:
19.00万
流通股本:
19.00万
量比:
1.13
换手率:
1.67%
股息:
0.93
股息率:
4.15%
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
没有相关数据
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
诺和诺德人员调整持续 新增招聘2000人
环球市场播报
·
11小时前
诺和诺德(NVO)股票4月15日盘中上涨3.55%:投资者必看的核心信息
TradingKey中文
·
昨天
诺和诺德与OpenAI达成战略合作;再生元牵手Telix
21世纪经济报道
·
04/15
诺和诺德全球高级副总裁兼大中国区总裁蔡琰:立足司美原研优势 挑战中寻找更大机遇
21世纪经济报道
·
04/15
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NVOH"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVOH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","market":"US","secType":"STK","nameCN":"Novo Nordisk A/S B Shares ADRhedged","latestPrice":22.3545,"timestamp":1776369600000,"preClose":22.2719,"halted":0,"volume":3176,"hourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.3545,"latestTime":"16:10 EDT","volume":6,"amount":134.127,"timestamp":1776370204125,"change":-0.0145,"changeRate":-0.000649,"amplitude":0},"delay":0,"changeRate":0.003708709180626839,"floatShares":190001,"shares":190001,"eps":0,"marketStatus":"未开盘","change":0.0826,"latestTime":"04-16 16:00:00 EDT","open":20.04,"high":22.39,"low":20.01,"amount":69084.2,"amplitude":0.106861,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1776412800000},"marketStatusCode":0,"adr":0,"exchange":"ARCA","adjPreClose":22.2719,"nav":22.290632,"aum":4235242.370632,"dividendRate":0.041535,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":22.34,"preClose":22.3545,"latestTime":"16:10 EDT","volume":6,"amount":134.127,"timestamp":1776370204125,"change":-0.0145,"changeRate":-0.000649,"amplitude":0},"volumeRatio":1.129124,"impliedVol":0.2556,"impliedVolPercentile":0.1818},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVOH\",,,,,undefined,":{"symbol":"NVOH","floatShares":190001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.129124,"shares":190001,"dividePrice":0.9285,"high":22.39,"amplitude":0.106861,"preClose":22.2719,"low":20.01,"week52Low":19,"pbRate":"--","week52High":43.73,"institutionHeld":0,"latestPrice":22.3545,"eps":0,"divideRate":0.041535,"volume":3176,"delay":0,"ttmEps":0,"open":20.04,"prevYearClose":27.4362,"prevWeekClose":20.6636,"prevMonthClose":20.5842,"prevQuarterClose":20.5842,"fiveDayClose":20.6683,"twentyDayClose":20.6,"sixtyDayClose":32.7865},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVOH\",params:#limit:5,,,undefined,":[{"date":"2026-03-16","symbol":"NVOH","amount":0.27495,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"NVOH","amount":0.48798,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"Novo Nordisk A/S B Shares ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"},{"date":"2025-09-16","symbol":"NVOH","amount":0.16566,"announcedDate":"2025-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-16","defaultRemindTime":1758029400000,"name":"Novo Nordisk A/S (B Shares) ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-16","currency":"USD","dateTimestamp":1757995200000,"payDate":"2025-09-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVOH\",market:\"US\",,,undefined,":[{"executeDate":"2025-09-16","recordDate":"2025-09-16","paymentDate":"2025-09-23","value":0.16566,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.48798,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.27495,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVOH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVOH\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2628324530","title":"诺和诺德人员调整持续 新增招聘2000人","url":"https://stock-news.laohu8.com/highlight/detail?id=2628324530","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628324530?lang=zh_cn&edition=fundamental","pubTime":"2026-04-17 03:06","pubTimestamp":1776366360,"startTime":"0","endTime":"0","summary":"诺德诺德在经历了一次相当大规模的人员重组之后,今年正在重新招人,新增约2000名员工。据报道,这些新员工中约有1400人已经入职,其中近400人在丹麦。与此同时,离职仍在发生。诺和诺德的员工自愿离职率为5%,而2025年的总流失率接近18%。在新任首席执行官Mike Doustdar领导的大规模重组中,公司裁减了约7800个职位,约占其员工总数的10%,2025年年底的员工总数约为69505人。此次裁员的影响范围并不局限于基层,也波及了高级管理层,足见变革之深。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-04-17/doc-inhutspq2543883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0154236417.USD","BK4007","LU1093756325.SGD","NVOX","BK4588","NVO","BK4585","BK4532","BK4599","LU1093756168.USD","NVOH","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627286232","title":"诺和诺德(NVO)股票4月15日盘中上涨3.55%:投资者必看的核心信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2627286232","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627286232?lang=zh_cn&edition=fundamental","pubTime":"2026-04-16 03:16","pubTimestamp":1776280594,"startTime":"0","endTime":"0","summary":"• 诺和诺德与 OpenAI 达成合作,旨在将人工智能整合到其业务运营的各个环节。\n• AI 旨在加强药物发现、生产制造和商业策略。\n• 此次合作被视为诺和诺德维持制药行业竞争力的催化剂。","market":"sg","thumbnail":"https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260204/novo-097495ca9dea48fc8abd9bbb031282c3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/261786892-market-movers-nvo-20260415","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7104","IE00BZ1G4Q59.USD","NVOH","BK4007","BK4588","BK4599","LU0154236417.USD","LU1093756325.SGD","NVO","IE00BKVL7J92.USD","NVOX","BK4585","LU1093756168.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627045478","title":"诺和诺德与OpenAI达成战略合作;再生元牵手Telix","url":"https://stock-news.laohu8.com/highlight/detail?id=2627045478","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627045478?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 08:01","pubTimestamp":1776211308,"startTime":"0","endTime":"0","summary":"政策动向国家医疗保障局持续开展定点医药机构违法违规使用医保基金自查自纠工作国家医疗保障局近日在全国范围内组织开展2026年定点医药机构违法违规使用医保基金自查自纠工作。自查自纠聚焦重点领域“逐渐细化、持续深化”。在既往心血管内科、骨科、血液净化、康复、医学影像、临床检验、肿瘤、麻醉、重症医学等9个重点领域的基础上,本年度进一步将口腔、内分泌、精神医学3个领域纳入自查自纠范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705224747.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705224747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOX","IE00BZ1G4Q59.USD","BK4599","301087","BK4007","LU1093756168.USD","IE00BKVL7J92.USD","688177","600513","600196","LU1093756325.SGD","NVO","002437","BK4532","REGN","LU0154236417.USD","BK4585","300558","NVOH","603087","02196","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627420487","title":"诺和诺德全球高级副总裁兼大中国区总裁蔡琰:立足司美原研优势 挑战中寻找更大机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=2627420487","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627420487?lang=zh_cn&edition=fundamental","pubTime":"2026-04-15 07:00","pubTimestamp":1776207600,"startTime":"0","endTime":"0","summary":"2026年3月,诺和诺德明星产品司美格鲁肽核心化合物在中国的专利到期。随着这一时间节点的到来,国内多款生物类似药的申报已进入冲刺阶段,市场对这家丹麦制药巨头在华策略的关注度持续升温。“专利到期不是终点。”履新刚满一个月的诺和诺德全球高级副总裁兼大中国区总裁蔡琰博士,在其首场媒体交流活动中给出了明确回应。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705008845.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705008845.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOH","BK4007","NVO","BK4585","LU0154236417.USD","IE00BKVL7J92.USD","BK4532","BK4599","LU1093756325.SGD","NVOX","BK4588","IE00BZ1G4Q59.USD","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/NVOH\",params:#limit:6,delay:false,,,undefined,":[]}}